UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone

Pharmacology, biochemistry and behavior, 2019-11, Vol.186, p.172778-172778, Article 172778

2019

Volltextzugriff (PDF)

Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount

Drug and alcohol dependence, 2017-10, Vol.179, p.362-369

2017

Volltextzugriff (PDF)

Polydrug abuse: A review of opioid and benzodiazepine combination use

Drug and alcohol dependence, 2012-09, Vol.125 (1), p.8-18

2012

Volltextzugriff (PDF)

Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and/or Alcohol Use

Postgraduate medicine, 2013-07, Vol.125 (4), p.115-130

2013

Volltextzugriff (PDF)

Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence

Neuropsychopharmacology (New York, N.Y.), 2017-08, Vol.42 (9), p.1825-1832

2017

Volltextzugriff (PDF)

Effects of Minocycline on Oxycodone‐Induced Responses in Humans

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder

Drug and alcohol dependence, 2020-03, Vol.208, p.107859-107859, Article 107859

2020

Volltextzugriff (PDF)

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

Pharmacology, biochemistry and behavior, 2017-12, Vol.163, p.90-100

2017

Volltextzugriff (PDF)

The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users

Physiology & behavior, 2016-05, Vol.159, p.33-39

2016

Volltextzugriff (PDF)

The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety

Journal of psychoactive drugs, 2018-10, Vol.50 (5), p.390-401

2018

Volltextzugriff (PDF)

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

Addiction biology, 2015-07, Vol.20 (4), p.784-798

2015

Volltextzugriff (PDF)

Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers

Neuropsychopharmacology (New York, N.Y.), 2013-11, Vol.38 (12), p.2427-2438

2013

Volltextzugriff (PDF)

The PPAR[gamma] Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety

Journal of psychoactive drugs, 2018-11, Vol.50 (5), p.390

2018

Volltextzugriff (PDF)

The effects of pioglitazone, a PPARy receptor agonist, on the abuse liability of oxycodone

Drug and alcohol dependence, 2015-01, Vol.146, p.e150-e150

2015

Volltextzugriff (PDF)

Baseline characteristics of patients predicting suitability for rapid naltrexone induction

The American journal on addictions, 2015-04, Vol.24 (3), p.258-264

2015

Volltextzugriff (PDF)

Patterns of opioid use and co-morbidity in non-treatment-seeking individuals with opioid use disorder

Drug and alcohol dependence, 2015-11, Vol.156, p.e139-e139

2015

Volltextzugriff (PDF)

Effects of minocycline on oxycodone-induced responses in humans

Drug and alcohol dependence, 2014-07, Vol.140, p.e153-e153

2014

Volltextzugriff (PDF)

Substituent Effects in Gas-Phase Substitutions and Eliminations: β-Halo Substituents. Solvation Reverses SN2 Substituent Effects

Journal of the American Chemical Society, 2001-04, Vol.123 (13), p.3081-3091

2001

Volltextzugriff (PDF)

Baseline characteristics of patients predicting suitability for rapid naltrexone induction

The American journal on addictions, 2014-12

2014

Volltextzugriff (PDF)

Substituent Effects in Gas-Phase Substitutions and Eliminations: β-Halo Substituents. Solvation Reverses S N 2 Substituent Effects

Journal of the American Chemical Society, 2001-04, Vol.123 (13), p.3081-3091

2001

Volltextzugriff (PDF)

Ab Initio Analysis of Lithium Dimethylaminoborohydride

Journal of organic chemistry, 2001-04, Vol.66 (7), p.2368-2373

2001

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Humans
(11)
Life Sciences & Biomedicine
(11)
Psychiatry
(9)
Adult
(8)
Female
(8)
Male
(8)
Heroin
(7)
Middle Aged
(6)
Opioids
(6)
Substance Abuse
(6)
Abuse Liability
(4)
Drug Abuse
(4)
Narcotics
(4)
Substance Abuse Treatment
(4)
Buprenorphine - Administration & Dosage
(3)
Dose-Response Relationship, Drug
(3)
Drug Addiction
(3)
Glia
(3)
Narcotic Antagonists - Administration & Dosage
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone

Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount

Polydrug abuse: A review of opioid and benzodiazepine combination use

Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and/or Alcohol Use

Effects of Ibudilast on the Subjective, Reinforcing, and Analgesic Effects of Oxycodone in Recently Detoxified Adults with Opioid Dependence

Effects of Minocycline on Oxycodone‐Induced Responses in Humans

Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder

Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential

The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users

The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety

Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users

Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers

The PPAR[gamma] Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety

The effects of pioglitazone, a PPARy receptor agonist, on the abuse liability of oxycodone

Baseline characteristics of patients predicting suitability for rapid naltrexone induction

Patterns of opioid use and co-morbidity in non-treatment-seeking individuals with opioid use disorder

Effects of minocycline on oxycodone-induced responses in humans

Substituent Effects in Gas-Phase Substitutions and Eliminations: β-Halo Substituents. Solvation Reverses SN2 Substituent Effects

Baseline characteristics of patients predicting suitability for rapid naltrexone induction

Substituent Effects in Gas-Phase Substitutions and Eliminations: β-Halo Substituents. Solvation Reverses S N 2 Substituent Effects

Ab Initio Analysis of Lithium Dimethylaminoborohydride

Suchergebnisse filtern